Cover Image
市場調查報告書

血液、細胞檢驗:全球市場的未來展望

Histology & Cytology - Global Market Outlook (2017-2023)

出版商 Stratistics Market Research Consulting 商品編碼 573080
出版日期 內容資訊 英文 201 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
血液、細胞檢驗:全球市場的未來展望 Histology & Cytology - Global Market Outlook (2017-2023)
出版日期: 2017年10月01日 內容資訊: 英文 201 Pages
簡介

本報告提供全球血液學的檢驗及細胞學的檢驗的市場相關分析,技術、相關疾病概要,及市場基本結構及促進、阻礙因素,產業的向心力、競爭環境,各檢驗對象、檢驗的各類型、各地區的市場趨勢預測 (過去3年、今後7年份),重要的資本交易的動向,主要企業簡介等調查。

第1章 摘要整理

第2章 序論

第3章 市場趨勢分析

  • 簡介
  • 市場的推動要素
  • 市場的阻礙要素
  • 市場機會
  • 威脅
  • 新興國家市場
  • 未來市場方案

第4章 波特的五力分析

  • 供應商談判力
  • 買主談判力
  • 替代產品的威脅
  • 新加入企業的威脅
  • 企業間競爭

第5章 全球血液、細胞檢驗市場:各檢驗對象

  • 簡介
  • 血液檢驗
  • 細胞檢驗
    • 乳癌
    • 子宮頸部癌症
    • 其他癌症

第6章 全球血液、細胞檢驗市場:檢驗的各類型

  • 簡介
  • 流式細胞技術
  • 顯微鏡檢驗
    • 免疫組織染色檢驗、免疫螢光檢驗
    • 細胞化學檢驗、組織化學檢驗
  • 分子遺傳學的檢驗
    • 聚合酵素鏈鎖反應
    • 細胞遺傳檢驗
      • FISH (螢光 in-situ 雜合反應)
      • 染色體組型分類

第7章 全球血液、細胞檢驗市場:各地區

  • 簡介
  • 北美 (美國,加拿大,墨西哥)
  • 歐洲 (德國,英國,法國,義大利,西班牙等)
  • 亞太地區 (日本,中國,印度,澳洲,紐西蘭,韓國等)
  • 南美 (阿根廷,巴西,智利等)
  • 中東、非洲 (沙烏地阿拉伯,UAE,卡達,南非等)

第8章 近幾年的主要趨勢

  • 協定,事業協定、合作,合資企業
  • 企業合併、收購 (M&A)
  • 新產品的銷售
  • 事業擴張
  • 其他主要策略

第9章 企業簡介

  • Abbott Laboratories
  • Dickinson and Company
  • Sysmex
  • Thermo Fisher Scientific, Inc
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Trivitron Healthcare
  • Life Technologies Corporation
  • Hologic, Inc
  • Merck KGaA

圖表一覽

目錄

According to Stratistics MRC, the Global Histology & Cytology market is expected to grow from $8.95 billion in 2016 to reach $22.25 billion by 2023 with a CAGR of 13.9%. Rapidly increasing incidence of cancer due to the environmental & lifestyle changes, rising standardization of pathology laboratories, scientific advancements in the cell, tissue studies and rising awareness about screening of cancer are likely to drive the market. Furthermore, uninterrupted R&D and arising acceptance of cytological tests are expected to be the vital reasons for the market growth.

On the basis of examination, cytology segment leads the histology & cytology market globally with the biggest market share. Cytology studies about the cell that carries on with the function, chemistry and structure of the examined cells. High particularity, adequate sensitiveness, and low cost are the advantages coupled with cytology segment. Thus, intensity of tests performed was high. Breast screening and cervix are the major applications of cytology. There is a big patient pool and handiness of products for the cervical cancer screening. Also, increasing investments by the key players for the advancement of tests is likely to increase demand for cervical cancer screening.

North America grabbed the top position in the global histology & cytology market. Decent coverage for diagnosis & treatment, government initiatives for the execution of high quality tone screening and accessibility of well-equipped diagnostic clinics are the factors responsible for the dominance of this region. Asia Pacific is expected to be the fastest growing region over the forecast period. Increasing geriatric population, growing cancer incidence and rising awareness about cancer screening in emerging economies such as India, China and Singapore are likely to drive the Asia Pacific histology & cytology market.

Some of the key players in Global Histology & Cytology market include Abbott Laboratories, Dickinson and Company, Sysmex Corporation, Thermo Fisher Scientific, Inc, Danaher, F. Hoffmann-La Roche Ltd, Trivitron Healthcare, Life Technologies Corporation, Hologic, Inc and Merck KGaA.

Examinations Covered:

  • Histology
  • Cytology

Type of Tests Covered:

  • Flow Cytometry
  • Microscopy Methods
  • Molecular Genetic Methods

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Histology & Cytology Market, By Type of Examination

  • 5.1 Introduction
  • 5.2 Histology
  • 5.3 Cytology
    • 5.3.1 Breast Cancer
    • 5.3.2 Cervical Cancer
    • 5.3.3 Other Cancers

6 Global Histology & Cytology Market, By Type of Tests

  • 6.1 Introduction
  • 6.2 Flow Cytometry
  • 6.3 Microscopy Methods
    • 6.3.1 Immunohistochemistry and Immunofluoroscence
    • 6.3.2 Cytochemistry and Histochemistry
  • 6.4 Molecular Genetic Methods
    • 6.4.1 Polymerase Chain Reaction
    • 6.4.2 Cytogenic Tests
      • 6.4.2.1 Fluorescent in Situ Hybridization (FISH)
      • 6.4.2.2 Karyotyping

7 Global Histology & Cytology Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Abbott Laboratories
  • 9.2 Dickinson and Company
  • 9.3 Sysmex Corporation
  • 9.4 Thermo Fisher Scientific, Inc
  • 9.5 Danaher
  • 9.6 F. Hoffmann-La Roche Ltd
  • 9.7 Trivitron Healthcare
  • 9.8 Life Technologies Corporation
  • 9.9 Hologic, Inc
  • 9.10 Merck KGaA

List of Tables

  • Table 1 Global Histology & Cytology Market Outlook, By Region (2014-2023) ($MN)
  • Table 2 Global Histology & Cytology Market Outlook, By Type of Examination (2014-2023) ($MN)
  • Table 3 Global Histology & Cytology Market Outlook, By Histology (2014-2023) ($MN)
  • Table 4 Global Histology & Cytology Market Outlook, By Cytology (2014-2023) ($MN)
  • Table 5 Global Histology & Cytology Market Outlook, By Breast Cancer (2014-2023) ($MN)
  • Table 6 Global Histology & Cytology Market Outlook, By Cervical Cancer (2014-2023) ($MN)
  • Table 7 Global Histology & Cytology Market Outlook, By Other Cancers (2014-2023) ($MN)
  • Table 8 Global Histology & Cytology Market Outlook, By Type of Tests (2014-2023) ($MN)
  • Table 9 Global Histology & Cytology Market Outlook, By Flow Cytometry (2014-2023) ($MN)
  • Table 10 Global Histology & Cytology Market Outlook, By Microscopy Methods (2014-2023) ($MN)
  • Table 11 Global Histology & Cytology Market Outlook, By Immunohistochemistry and Immunofluoroscence (2014-2023) ($MN)
  • Table 12 Global Histology & Cytology Market Outlook, By Cytochemistry and Histochemistry (2014-2023) ($MN)
  • Table 13 Global Histology & Cytology Market Outlook, By Molecular Genetic Methods (2014-2023) ($MN)
  • Table 14 Global Histology & Cytology Market Outlook, By Polymerase Chain Reaction (2014-2023) ($MN)
  • Table 15 Global Histology & Cytology Market Outlook, By Cytogenic Tests (2014-2023) ($MN)
  • Table 16 Global Histology & Cytology Market Outlook, By Fluorescent In Situ Hybridization (FISH) (2014-2023) ($MN)
  • Table 17 Global Histology & Cytology Market Outlook, By Karyotyping (2014-2023) ($MN)
  • Table 18 North America Histology & Cytology Market Outlook, By Country (2014-2023) ($MN)
  • Table 19 North America Histology & Cytology Market Outlook, By Type of Examination (2014-2023) ($MN)
  • Table 20 North America Histology & Cytology Market Outlook, By Histology (2014-2023) ($MN)
  • Table 21 North America Histology & Cytology Market Outlook, By Cytology (2014-2023) ($MN)
  • Table 22 North America Histology & Cytology Market Outlook, By Breast Cancer (2014-2023) ($MN)
  • Table 23 North America Histology & Cytology Market Outlook, By Cervical Cancer (2014-2023) ($MN)
  • Table 24 North America Histology & Cytology Market Outlook, By Other Cancers (2014-2023) ($MN)
  • Table 25 North America Histology & Cytology Market Outlook, By Type of Tests (2014-2023) ($MN)
  • Table 26 North America Histology & Cytology Market Outlook, By Flow Cytometry (2014-2023) ($MN)
  • Table 27 North America Histology & Cytology Market Outlook, By Microscopy Methods (2014-2023) ($MN)
  • Table 28 North America Histology & Cytology Market Outlook, By Immunohistochemistry and Immunofluoroscence (2014-2023) ($MN)
  • Table 29 North America Histology & Cytology Market Outlook, By Cytochemistry and Histochemistry (2014-2023) ($MN)
  • Table 30 North America Histology & Cytology Market Outlook, By Molecular Genetic Methods (2014-2023) ($MN)
  • Table 31 North America Histology & Cytology Market Outlook, By Polymerase Chain Reaction (2014-2023) ($MN)
  • Table 32 North America Histology & Cytology Market Outlook, By Cytogenic Tests (2014-2023) ($MN)
  • Table 33 North America Histology & Cytology Market Outlook, By Fluorescent In Situ Hybridization (FISH) (2014-2023) ($MN)
  • Table 34 North America Histology & Cytology Market Outlook, By Karyotyping (2014-2023) ($MN)
  • Table 35 Europe Histology & Cytology Market Outlook, By Country (2014-2023) ($MN)
  • Table 36 Europe Histology & Cytology Market Outlook, By Type of Examination (2014-2023) ($MN)
  • Table 37 Europe Histology & Cytology Market Outlook, By Histology (2014-2023) ($MN)
  • Table 38 Europe Histology & Cytology Market Outlook, By Cytology (2014-2023) ($MN)
  • Table 39 Europe Histology & Cytology Market Outlook, By Breast Cancer (2014-2023) ($MN)
  • Table 40 Europe Histology & Cytology Market Outlook, By Cervical Cancer (2014-2023) ($MN)
  • Table 41 Europe Histology & Cytology Market Outlook, By Other Cancers (2014-2023) ($MN)
  • Table 42 Europe Histology & Cytology Market Outlook, By Type of Tests (2014-2023) ($MN)
  • Table 43 Europe Histology & Cytology Market Outlook, By Flow Cytometry (2014-2023) ($MN)
  • Table 44 Europe Histology & Cytology Market Outlook, By Microscopy Methods (2014-2023) ($MN)
  • Table 45 Europe Histology & Cytology Market Outlook, By Immunohistochemistry and Immunofluoroscence (2014-2023) ($MN)
  • Table 46 Europe Histology & Cytology Market Outlook, By Cytochemistry and Histochemistry (2014-2023) ($MN)
  • Table 47 Europe Histology & Cytology Market Outlook, By Molecular Genetic Methods (2014-2023) ($MN)
  • Table 48 Europe Histology & Cytology Market Outlook, By Polymerase Chain Reaction (2014-2023) ($MN)
  • Table 49 Europe Histology & Cytology Market Outlook, By Cytogenic Tests (2014-2023) ($MN)
  • Table 50 Europe Histology & Cytology Market Outlook, By Fluorescent In Situ Hybridization (FISH) (2014-2023) ($MN)
  • Table 51 Europe Histology & Cytology Market Outlook, By Karyotyping (2014-2023) ($MN)
  • Table 52 Asia Pacific Histology & Cytology Market Outlook, By Country (2014-2023) ($MN)
  • Table 53 Asia Pacific Histology & Cytology Market Outlook, By Type of Examination (2014-2023) ($MN)
  • Table 54 Asia Pacific Histology & Cytology Market Outlook, By Histology (2014-2023) ($MN)
  • Table 55 Asia Pacific Histology & Cytology Market Outlook, By Cytology (2014-2023) ($MN)
  • Table 56 Asia Pacific Histology & Cytology Market Outlook, By Breast Cancer (2014-2023) ($MN)
  • Table 57 Asia Pacific Histology & Cytology Market Outlook, By Cervical Cancer (2014-2023) ($MN)
  • Table 58 Asia Pacific Histology & Cytology Market Outlook, By Other Cancers (2014-2023) ($MN)
  • Table 59 Asia Pacific Histology & Cytology Market Outlook, By Type of Tests (2014-2023) ($MN)
  • Table 60 Asia Pacific Histology & Cytology Market Outlook, By Flow Cytometry (2014-2023) ($MN)
  • Table 61 Asia Pacific Histology & Cytology Market Outlook, By Microscopy Methods (2014-2023) ($MN)
  • Table 62 Asia Pacific Histology & Cytology Market Outlook, By Immunohistochemistry and Immunofluoroscence (2014-2023) ($MN)
  • Table 63 Asia Pacific Histology & Cytology Market Outlook, By Cytochemistry and Histochemistry (2014-2023) ($MN)
  • Table 64 Asia Pacific Histology & Cytology Market Outlook, By Molecular Genetic Methods (2014-2023) ($MN)
  • Table 65 Asia Pacific Histology & Cytology Market Outlook, By Polymerase Chain Reaction (2014-2023) ($MN)
  • Table 66 Asia Pacific Histology & Cytology Market Outlook, By Cytogenic Tests (2014-2023) ($MN)
  • Table 67 Asia Pacific Histology & Cytology Market Outlook, By Fluorescent In Situ Hybridization (FISH) (2014-2023) ($MN)
  • Table 68 Asia Pacific Histology & Cytology Market Outlook, By Karyotyping (2014-2023) ($MN)
  • Table 69 South America Histology & Cytology Market Outlook, By Country (2014-2023) ($MN)
  • Table 70 South America Histology & Cytology Market Outlook, By Type of Examination (2014-2023) ($MN)
  • Table 71 South America Histology & Cytology Market Outlook, By Histology (2014-2023) ($MN)
  • Table 72 South America Histology & Cytology Market Outlook, By Cytology (2014-2023) ($MN)
  • Table 73 South America Histology & Cytology Market Outlook, By Breast Cancer (2014-2023) ($MN)
  • Table 74 South America Histology & Cytology Market Outlook, By Cervical Cancer (2014-2023) ($MN)
  • Table 75 South America Histology & Cytology Market Outlook, By Other Cancers (2014-2023) ($MN)
  • Table 76 South America Histology & Cytology Market Outlook, By Type of Tests (2014-2023) ($MN)
  • Table 77 South America Histology & Cytology Market Outlook, By Flow Cytometry (2014-2023) ($MN)
  • Table 78 South America Histology & Cytology Market Outlook, By Microscopy Methods (2014-2023) ($MN)
  • Table 79 South America Histology & Cytology Market Outlook, By Immunohistochemistry and Immunofluoroscence (2014-2023) ($MN)
  • Table 80 South America Histology & Cytology Market Outlook, By Cytochemistry and Histochemistry (2014-2023) ($MN)
  • Table 81 South America Histology & Cytology Market Outlook, By Molecular Genetic Methods (2014-2023) ($MN)
  • Table 82 South America Histology & Cytology Market Outlook, By Polymerase Chain Reaction (2014-2023) ($MN)
  • Table 83 South America Histology & Cytology Market Outlook, By Cytogenic Tests (2014-2023) ($MN)
  • Table 84 South America Histology & Cytology Market Outlook, By Fluorescent In Situ Hybridization (FISH) (2014-2023) ($MN)
  • Table 85 South America Histology & Cytology Market Outlook, By Karyotyping (2014-2023) ($MN)
  • Table 86 Middle East & Africa Histology & Cytology Market Outlook, By Country (2014-2023) ($MN)
  • Table 87 Middle East & Africa Histology & Cytology Market Outlook, By Type of Examination (2014-2023) ($MN)
  • Table 88 Middle East & Africa Histology & Cytology Market Outlook, By Histology (2014-2023) ($MN)
  • Table 89 Middle East & Africa Histology & Cytology Market Outlook, By Cytology (2014-2023) ($MN)
  • Table 90 Middle East & Africa Histology & Cytology Market Outlook, By Breast Cancer (2014-2023) ($MN)
  • Table 91 Middle East & Africa Histology & Cytology Market Outlook, By Cervical Cancer (2014-2023) ($MN)
  • Table 92 Middle East & Africa Histology & Cytology Market Outlook, By Other Cancers (2014-2023) ($MN)
  • Table 93 Middle East & Africa Histology & Cytology Market Outlook, By Type of Tests (2014-2023) ($MN)
  • Table 94 Middle East & Africa Histology & Cytology Market Outlook, By Flow Cytometry (2014-2023) ($MN)
  • Table 95 Middle East & Africa Histology & Cytology Market Outlook, By Microscopy Methods (2014-2023) ($MN)
  • Table 96 Middle East & Africa Histology & Cytology Market Outlook, By Immunohistochemistry and Immunofluoroscence (2014-2023) ($MN)
  • Table 97 Middle East & Africa Histology & Cytology Market Outlook, By Cytochemistry and Histochemistry (2014-2023) ($MN)
  • Table 98 Middle East & Africa Histology & Cytology Market Outlook, By Molecular Genetic Methods (2014-2023) ($MN)
  • Table 99 Middle East & Africa Histology & Cytology Market Outlook, By Polymerase Chain Reaction (2014-2023) ($MN)
  • Table 100 Middle East & Africa Histology & Cytology Market Outlook, By Cytogenic Tests (2014-2023) ($MN)
  • Table 101 Middle East & Africa Histology & Cytology Market Outlook, By Fluorescent In Situ Hybridization (FISH) (2014-2023) ($MN)
  • Table 102 Middle East & Africa Histology & Cytology Market Outlook, By Karyotyping (2014-2023) ($MN)
Back to Top